Skip to main content
. 2016 May 1;10(5):ZC134–ZC137. doi: 10.7860/JCDR/2016/16338.7870

[Table/Fig-3]:

Baseline characteristics of the study participants.

Placebo
n=8
Curcumin
n=12
Age (mean±S.D.) 52.75± 9.43 49.42± 11.22
Male 5 (62.5%) 2 (16.7%)
Female 3 (37.3%) 10 (83.3%)
History of previous treatment 5 (62.5%) 4 (33.3%)
Skin involvement 1 (12.5%) 2 (16.7%)
Site of OLP
  Bucal 8 (62%) 10 (47%)
  Tongue 4 (31%) 6 (25%)
  Gingiva 0 5 (23%)
  Lip 1 (7%) 1 (5%)
Systemic disease 4 (50%) 7(58.3%)
Pain and sensation score (mean±S.D.) 4.63±3.20 6.5±2.15
Thangprasom score 3±1.30 3.17±1.03